Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell TransplantationAlex F. Herrera, Philippe Armand, Matthew Mei et al.|Journal of Clinical Oncology|2016Cited by 187
Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host DiseaseBadri Modi, Ryotaro Nakamura, Sanjeet Dadwal et al.|Biology of Blood and Marrow Transplantation|2018Cited by 84